Astec LifeSciences (NSE:ASTEC, BOM:533138) has received board approval to raise up to 2.50 billion Indian rupees through a rights issue of shares, according to a Tuesday filing with the Indian stock exchanges.
The board approved the issue of fully paid-up equity shares of the company of face value of 10 rupees each by way of a rights issue to the eligible equity shareholders of the company.
The record date for the issue will be decided later.
The company's shares were up over 7% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.